Lumbar transplants of immortalized serotonergic neurons alleviate chronic neuropathic pain

Pain

Volumn 72, Issue 1-2, 1997, Pages 59-69

  Eaton, M J ^a   Santiago, D I ^a   Dancausse, H A ^a   Whittemore, S R ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Brain derived neurotrophic factor (BDNF); Chronic constriction injury; Neural cell lines; Serotonin; Transplantation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CHRONIC PAIN; CONTROLLED STUDY; HYPERALGESIA; LUMBAR SPINAL CORD; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SEROTONINERGIC NERVE CELL;

EID: 0030791867     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00015-8     Document Type: Article

References (86)

1. Aimone, L.D., Jones, S.L. and Gebhart, G.F., Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids, Pain, 31 (1987) 123–136.
2. Anden, N.E., Jukes, M.G.M. and Lundberg, A., Spinal reflexes and monoamine liberation, Nature, 202 (1964) 1222–1223.
3. Attal, N., Jazat, F., Kayser, V. and Guilbaud, G., Further evidence for pain-related behaviors in a model of unilateral peripheral mononeuropathy, Pain, 41 (1990) 235–251.
4. Barbaro, N.M., Hammond, D.L. and Fields, H.L., Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat, Brain Res., 343 (1985) 223–229.
5. Basbaum, A.L. and Fields, H.L., Endogenous pain control systems: brain stem spinal pathways and endorphin circuitry, Annu. Rev. Neurosci., 7 (1984) 309–338.
6. Beck, K.D., Knusel, B. and Hefti, F., The nature of the tropic action of brain-derived neurotropic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture, Neuroscience, 52 (1993) 855–866.
7. Belcher, G., Ryall, R.W. and Schaffner, R., The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurons in the cat, Brain Res., 151 (1978) 307–321.
8. Bennett, G.J. and Xie, Y.-K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, 33 (1988) 87–107.
9. Bervoets, K., Millan, M.J. and Colpaert, F.C., Agonist action at 5HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat, Eur. J. Pharmacol., 191 (1990) 185–195.
10. Bervoets, K., Rivet, J.M. and Millan, M.J., 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotonergic neurones mediate spontaneous tail-flicks in the rat, J. Pharmacol. Exp. Ther., 264 (1993) 95–104.
11. Bervoets, K. and Millan, M.J., 5-HT1A receptors and the tail flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-licks by α 1A- as compared with α 2D-adrenoceptors in rat lumbar spinal cord, J. Pharmacol. Exp. Ther., 269 (1994) 110–120.
12. Besson, J.-M., Serotonin and Pain, Excerpta Medica, New York, 1990.
13. Besson, J.-M. and Chaouch, A., Peripheral and spinal mechanisms of nociception, Physiol. Rev., 67 (1987) 67–186.
14. Björklund, A., Neural transplantation – an experimental tool with clinical possibilities, Trends Neurosci., 14 (1991) 319–322.
15. Bourgoin, S., Oliveras, J.L., Bruxelle, J., Hamon, M. and Besson, J.-M., Electrical stimulation of the nucleus raphe magnus in the rat. Effects on 5-HT metabolism in the spinal cord, Brain Res., 194 (1980) 377–389.
16. Brune, K.I. and Lanz, R., Nonopioid analgesics. In: M. Kuhar and G. Pasternak (Eds.). Analgesics: Neurochemical, Behavioral and Clinical Perspectives, Raven Press, New York, 1984, pp. 149–173.
17. Butler, S., Present status of tricylic antidepressants in chronic pain therapy. In: C. Benedetti, C.R. Chapman and G. Moricca (Eds.), Advances in Pain Research and Therapy, Raven Press, New York, 1984, pp. 173–197.
18. Carlsson, A., Falck, B., Fuxe, K. and Hillarp, N-A., Cellular localization of monoamines in the spinal cord, Acta Physiol. Scand., 59 (1964) 126–142.
19. Celada, P., Siuciak, J.A., Tran, T.M., Altar, C.A. and Tepper, J.M., Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons, Brain Res., 712 (1996) 293–298.
20. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. and Yaksh, T.L., Quantitative assessment of tactile allodynia in the rat paw, J. Neurosci. Methods, 53 (1994) 55–63.
21. Czech, K.A. and Sagen, J., Update on cellular transplantation into the CNS as a novel therapy for chronic pain, Prog. Neurobiol., 46 (1995) 507–529.
22. Davies, J.E. and Roberts, M.H.T., 5-hydroxytryptamine reduces substance P responses on dorsal interneurones: a possible interaction of neurotransmitters, Brain Res., 217 (1981) 399–404.
23. Eaton, M.J., Staley, J.K., Globus, M.Y.-T. and Whittemore, S.R., Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization, Dev. Biol., 170 (1995) 169–182.
24. Eaton, M.J., Dancausse, H.A. and Rabade, J., Grafted neuronal serotonergic precursors alleviate chronic neuropathic pain and reverse the loss of GABA after sciatic nerve constriction, Int. Neur. Trans. Soc., (1996a) Abstr.
25. Eaton, M.J., Santiago, D.I., Dancausse, H.A. and Whittemore, S.R., Lumbar transplants of serotonergic neurons alleviates chronic neuropathic pain, Am. Pain. Soc. Abs., (1996b) Abstr.
26. Eaton, M.J., Santiago, D.I., Dancausse, H.A. and Whittemore, S.R., Autocrine BDNF secretion enhances the survival and serotonergic differentiation of grafted raphe neuronal precursor cells and lumbar transplants alleviate chronic neuropathic pain, Soc. Neurosci. Abstr., (1996c).
27. Eaton, M.J. and Whittemore, S.R., Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS, Exp. Neurol., 140 (1996) 105–114.
28. El-Yassir, N., Fleetwood-Walker, S.M. and Mitchell, R., Heterogeneous effects of serotonin in the dorsal horn of the rat: the involvement of 5-HT1 receptor subtypes, Brain Res., 456 (1988) 147–158.
29. Farakash, A.E. and Portney, R.K., The pharmacological management of chronic pain in the paraplegic patient, J. Am. Paraplegia Soc., 9 (1986) 41–50.
30. 1A receptor, J. Biol. Chem., 2645 (1989) 14848–14852.
31. i protein, Cell, 3 (1991) 547–557.
32. Foley, K.M. and Inturrsi, C.E., Advances in Pain Research and Therapy, Vol. 8, Raven Press, New York, 1986, 466 pp.
33. Gebhart, G.F. and Jones, S.L., Effects of morphine given in the brain stem on the activity of dorsal horn nociceptive neurons, Prog. Brain Res., 77 (1988) 229–243.
34. Gildenberg, P.L. and DeVaul, R.A., The Chronic Pain Patient, Karger, New York, 1985.
35. Hama, A.T. and Sagen, J., Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy, Pain, 52 (1994) 223–231.
36. Hammond, D.L. and Yaksh, T.L., Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine, Brain Res., 298 (1984) 329–337.
37. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32 (1988) 77–88.
38. Hofer, M.M. and Barde, Y.-A., Brain-derived neurotrophic factor prevents neuronal death in vivo, Nature, 331 (1988) 261–262.
39. Jones, S.L., Descending control of nociception. In: A.R. Light (Ed.). The Initial Processing of Pain and its Descending Control: Spinal and Trigeminal Systems, Karger, New York, 1992, pp. 203–295.
40. Kawamoto, J.C. and Barrett, J.N., Cryopreservation of primary neurons for tissue culture, Brain Res., 384 (1986) 84–93.
41. Kim, S.H. and Chung, J.M., An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain, 50 (1992) 355–363.
42. Kuraishi, Y., Hirota, N., Satoh, M. and Takagi, H., Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests, Brain Res., 326 (1985) 168–171.
43. LeBars, D., In: N.N. Osborne and M. Hamon (Eds.), Neuronal Serotonin, Wiley, New York, 1988, pp. 171–229.
44. Lima, D., Endogenous pain modulatory system in the light of the gate control theory, Pain Forum, 5 (1996) 31–39.
45. Loeser, J.D., Peripheral nerve disorders. In: J.J. Bonica (Ed.), The Management of Pain, Lea and Febiger, Philadelphia, PA, 1990, pp. 211–219.
46. Lundberg, A., Supraspinal control of transmission in reflex paths to motorneurons and primary afferents. In: J.C. Eccles and J.P. Schade (Eds.), Physiology of Spinal Neurons, Elsevier, Amersterdam, 1964, pp. 197–219.
47. Mamounas, L.A., Blue, M.E., Siuciak, J.A. and Altar, C.A., Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain, J. Neurosci., 15 (1995) 7929–7939.
48. Martin-Iverson, M.T., Todd, K.G. and Altar, C.A., Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine, J. Neurosci., 14 (1994) 1262–1270.
49. Millan, M.J., Bervoets, K. and Colpaert, F.C., Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks, Neurosci. Lett., 107 (1989) 227–232.
50. 1A receptor-mediated activity, J. Pharmacol. Exp. Ther., 256 (1991) 973–982.
51. Millan, M.J., Evidence that an α 2A-adrenoceptor subtype mediates antinociception in mice, Eur. J. Pharmacol., 215 (1992) 355–356.
52. Millan, M.J., Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice, Pain, 58 (1994) 45–61.
53. Millan, M.J. and Colpaert, F.C., Attenuation of opioid induced antinociception by 5-HT1A partial agonists in the rat, Neuropharmacology, 29 (1990) 315–318.
54. Millan, M.J. and Colpaert, F.C., 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate μ - but not κ -opioid antinociception in mice and rats, J. Pharmacol. Exp. Ther., 256 (1991a) 993–1001.
55. Millan, M.J. and Colpaert, F.C., Methylenediomethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors, Eur. J. Pharmacol., 193 (1991b) 145–152.
56. Monks, R. and Mersky, H., Psychotropic drugs. In: P. D. Wall and R. M. Melzack (Eds.), Textbook of Pain, Churchhill Livingston, Edinburgh, 1984, pp. 526–537.
57. Morgan, M.M., Descending modulation and nociceptive transmission, Pain Forum, 5 (1996) 23–27.
58. Ohsawa, F., Widmer, H.R., Knusel, B., Denton, T.L. and Hefti, F., Response of embryonic rat hippocampal neurons in culture to neurotropin-3, brain-derived neurotrophic factor and basic fibroblast factor, Neuroscience, 57 (1993) 67–77.
59. Rivot, J.P., Chiang, C.Y. and Besson, J.-M., Increase of serotonin metabolism with the dorsal horn of the spinal cord during nucleus raphe magnus stimulation, as revealed by in vivo electrochemical detection, Brain Res., 238 (1982) 117–126.
60. Roberts, M.H.T., Davies, M., Girdlestone, D. and Foster, G.A., Effects of 5-hydroxytrptamine agonists and antagonists on the responses of rat spinal motorneurones to raphe obscurus stimulation, Br. J. Pharmacol., 95 (1988) 437–448.
61. Sagen, J., Pappas, G.D. and Perlow, M.J., Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity, Brain Res., 384 (1986) 189–194.
62. Sagen, J., Pappas, G.D. and Ortega, J.D., Host-graft relationships of isolated bovine chromaffin cells in rat periaqueductal grey, J. Neurocytol., 19 (1990a) 697–707.
63. Sagen, J., Wang, H. and Pappas, G.D., Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model, Pain, 42 (1990b) 69–79.
64. Sagen, J., Kemmler, J.E. and Wang, H., Adrenal medullary transplants increase spinal cord cerebral spinal fluid catecholamine levels and reduce pain sensitivity, J. Neurochem., 56 (1991) 623–627.
65. Sagen, J., Wang, H., Tresco, P.A. and Aebischer, P., Transplants of immunologically isolated xenogenic chromaffin cells provide a long-term source of pain-reducing neuroactive substances, J. Neurosci., 13 (1993) 2415–2423.
66. Sagen, J. and Kemmler, J.E., Increased levels of met-enkephalin like-immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants, Brain Res., 502 (1989) 1–10.
67. Schmauss, C., Hammond, D.L., Ochi, J.W. and Yaksh, T.L., Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord, Eur. J. Pharmacol., 90 (1983) 349–357.
68. Shihabuddin, L.S., Hertz, J.A., Holets, V.R. and Whittemore, S.R., The adult CNS retains the potential to direct region-specific differentiation of a transplanted neuronal precursor cell line, J. Neurosci., 15 (1995) 6666–6678.
69. Siuciak, J.A., Altar, C.A., Wiegand, S.J. and Lindsay, R.M., Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3, Brain Res., 63 (1994) 326–330.
70. Solomon, R.E. and Gebhart, G.F., Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats, J. Pharmacol. Exp. Ther., 245 (1988) 905–912.
71. Swerdlow, M., Review: anticonvulsant drugs and chronic pain, Clin. Neuropharmacol., 7 (1984) 51–84.
72. Tive, L.A. and Barr, G.A., Analgesia from the periaqueductal gray in the developing rat: focal injections of morphine or glutamate and effects of intrathecal injection of methysergide or phentolamine, Brain Res., 584 (1992) 92–109.
73. Wang, H. and Sagen, J., Optimization of adrenal medullary allograft conditions for pain alleviation, J. Neural Trans. Plastic., 5 (1994) 49–64.
74. Wang, J.K., Antinociceptive effect of intrathecally administered serotonin, Anesthesiology, 47 (1977) 269–271.
75. White, L.A., Eaton, M.J., Castro, M.C., et al., Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons, J. Neurosci., 14 (1994) 6744–6753.
76. Winnie, A.P., Pappas, G.D., DasGupta, T.K., Wang, H., Ortega, J.D. and Sagen, J., Subarachnoid adrenal medullary transplants for terminal cancer pain, Anesthesiology, 79 (1993) 644–653.
77. Wu, H.H., McLoon, S.C. and Wilcox, G.L., Antinociception following implantation of ATT-20 and genetically modified AtT-20/hENK cells in rat spinal cord, J. Neural Trans. Plastic., 4 (1993) 15–26.
78. Wu, H.H., Lester, B.R., Sun, Z. and Wilcox, G.L., Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord, Pain, 56 (1994a) 203–210.
79. Wu, H.H., Wilcox, G.L. and McLoon, S.C., Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance, J. Neurosci., 14 (1994b) 4806–4814.
80. Xu, X.M., Guenard, V., Kleitman, N. and Bunge, M.B., A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord, Dev. Biol., 168 (1995) 124–137.
81. Yaksh, T.L. and Wilson, P.R., Spinal serotonin terminal system mediates antinociception, J. Pharmacol. Exp. Ther., 208 (1979) 446–453.
82. Yezierski, R.P., Pain following spinal cord injury: the clinical problem and experimental studies, Pain, 68: (1996) 185–194.
83. Yezierski, R.P., Liu, S., Ruenes, G.L. and Kajander, K.J., Behavioral and pathological characteristics of a central pain model following spinal injury, VIIIth World Congress on Pain, 1996.
84. Yong, V.W. and Kim, S.U., A new double labelling immunofluorescence technique for the determination of proliferation of human astrocytes in culture, J. Neurosci. Methods, 21 (1987) 9–16.
85. Zemlan, F.P., Behbehani, M.M. and Murphy, R.M., Serotonin receptor subtypes and the modulation of pain transmission, Prog. Brain Res., 77 (1988) 349–355.
86. Zhuo, M. and Gebhart, G.F., Inhibition of a cutaneous nociceptive reflex by a noxious visceral stimulus is mediated by spinal cholinergic and descending serotonergic systems in the rat, Brain Res., 585 (1992) 7–18.